News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioTie Therapies Corp. Interim Report 1 January - 30 September 2012


11/2/2012 7:25:38 AM

July - September 2012

* Biotie completed a directed share issue of EUR 20 million to institutional and strategic investors.
* Lundbeck made a EUR 10 Million equity investment in Biotie with a 25% premium and the parties amended the Selincro licensing agreement regarding territories outside the EU and US.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES